BR9713355A - Proteìna de ligação à lactoferrina d streptococcus uberis - Google Patents

Proteìna de ligação à lactoferrina d streptococcus uberis

Info

Publication number
BR9713355A
BR9713355A BR9713355-8A BR9713355A BR9713355A BR 9713355 A BR9713355 A BR 9713355A BR 9713355 A BR9713355 A BR 9713355A BR 9713355 A BR9713355 A BR 9713355A
Authority
BR
Brazil
Prior art keywords
uberis
binding protein
lactoferrin
streptococcus uberis
blf
Prior art date
Application number
BR9713355-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Min Jiang
Andrew A Potter
Philip Ronald Maclachlan
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of BR9713355A publication Critical patent/BR9713355A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9713355-8A 1996-11-14 1997-11-14 Proteìna de ligação à lactoferrina d streptococcus uberis BR9713355A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3111796P 1996-11-14 1996-11-14
PCT/CA1997/000867 WO1998021231A2 (en) 1996-11-14 1997-11-14 Streptococcus uberis lactoferrin-binding protein

Publications (1)

Publication Number Publication Date
BR9713355A true BR9713355A (pt) 2000-01-25

Family

ID=21857732

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713355-8A BR9713355A (pt) 1996-11-14 1997-11-14 Proteìna de ligação à lactoferrina d streptococcus uberis

Country Status (8)

Country Link
EP (1) EP0948528A2 (de)
JP (1) JP2001504335A (de)
KR (1) KR20000068980A (de)
AU (1) AU5044198A (de)
BR (1) BR9713355A (de)
CA (1) CA2270404A1 (de)
IL (1) IL129566A0 (de)
WO (1) WO1998021231A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2507163C (en) 2002-11-26 2012-09-25 University Of Tennessee Research Foundation Streptococcus uberis adhesion molecule
WO2009052572A1 (en) * 2007-10-25 2009-04-30 The University Of Queensland Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
GB0818231D0 (en) * 2008-10-06 2008-11-12 Univ Nottingham Composition
PL246485B1 (pl) 2022-08-25 2025-02-03 Univ Jagiellonski Sposób i kompozycja diagnostyczna do wykrywania mastitis wywołanego przez E. coli, S. uberis, S. agalactiae lub S. aureus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9201013D0 (en) * 1992-01-17 1992-03-11 Animal Health Inst Vaccines
WO1996041879A1 (en) * 1995-06-08 1996-12-27 University Of Saskatchewan Camp factor of streptococcus uberis

Also Published As

Publication number Publication date
EP0948528A2 (de) 1999-10-13
JP2001504335A (ja) 2001-04-03
WO1998021231A3 (en) 1998-08-27
CA2270404A1 (en) 1998-05-22
WO1998021231A2 (en) 1998-05-22
AU5044198A (en) 1998-06-03
KR20000068980A (ko) 2000-11-25
IL129566A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
BR0011103A (pt) Composição farmacêutica, e, métodos para prevenção ou tratamento de um distúrbio caracterizado por deposição amilóide em um sujeito mamìfero, para determinar o prognóstico de um paciente que está sendo submetido a tratamento de um distúrbio amilóide e para prevenção ou tratamento de uma doença caracterizada por um depósito amilóide em um paciente
BRPI9915208A (pt) preparados farmacêutico e de comprimido para a aplicação oral compreendendo moxifloxacina e seu processo de preparação.
ES2124203T1 (es) Inhibidores de elastasa de neutrofilos humanos y catepsina g humana.
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
BR0014155A (pt) Prevenção da miocardite, do aborto e da infecção intrauterina, associados com o circovìrus-2 porcino
DE69533544D1 (de) Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
ATE223230T1 (de) Pulmonäre verabreichung des löslichen komplement- receptors typ 1 scr1
DE69637914D1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
BRPI0013010B8 (pt) formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
BR9808812A (pt) Composição compreendendo partìculas cristalinas, finamente divididas de budesonida
MX9602570A (es) Metodos y materiales anti-fungosos.
BR9914631A (pt) Composição imunológica oral indutora de tolerância para prevenção e/ou tratamento de enfermidades e método para prevenção e/ou tratamento de enfermidades
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DK1082131T3 (da) Immunoregulator
BR9712466A (pt) Aplicação de adamantanaminas ou compostos de estrutura análogo para combater o vìrus da doença de borna e para a profilaxia e tratamento de doenças emocionais e outras perturbaçoes ligadas com infecçoes do vìrus bd homem e animal
BR9713355A (pt) Proteìna de ligação à lactoferrina d streptococcus uberis
BR9916549A (pt) Composição farmacêutica, vacina, proteìna, e, método para a prevenção ou tratamento de leishmaniose em um humano ou animal
PT90739A (pt) Processo para a preparacao de uma proteina dotada de actividade de inibicao de trombina
NO954888D0 (no) Farmasöytiske preparater og deres anvendelse, særlig for behandling av neuro-degenerative sykdommer
BR9510323A (pt) Variante de dnase i humana ácido nucleico isolado método para tratamento de um paciente tendo uma desordem ou doença pulmonar e composição farmacêutica
NZ334762A (en) Human DNase I variants having binding affinity to actin
BRPI0417933A (pt) composto, métodos para o tratamento ou a profilaxia de uma doença ou condição, e de distúrbios, e para a indução da cessação do hábito de fumar, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]